Smart. Sharp. Funny. Fearless.
Monday, December 10, 2018

Danziger: Paging Dr. Frankenstein

Jeff Danziger lives in New York City. He is represented by CWS Syndicate and the Washington Post Writers Group. He is the recipient of the Herblock Prize and the Thomas Nast (Landau) Prize. He served in the US Army in Vietnam and was awarded the Bronze Star and the Air Medal. He has published eleven books of cartoons and one novel. Visit him at

Trump Calls Halt To Medical Progress Over Stem Cell Research

Reprinted with permission from Shareblue.


The Trump administration is considering cutting $100 million worth of crucial medical research into developing new vaccines and treating diseases like Parkinson’s and Alzheimer’s.

“It will slow some projects down that are vital for sick Americans,” Larry Goldstein, the director of UC San Diego’s stem cell program, told Politico, blasting the proposal by the Department of Health and Human Services (HHS) to discontinue National Institutes of Health (NIH) research that uses fetal tissue.

Research on stem cells derived from fetal tissue is absolutely essential to medical progress. It brought us the vaccines for polio and measles, and it’s currently being used to develop potential vaccines for HIV/AIDS and influenza, as well as treatments for neurodegenerative diseases like Parkinson’s, Alzheimer’s, ALS, and more.…

Read More

Top Cancer Researcher Failed To Properly Disclose Pharma Ties

Reprinted with permission from ProPublica.

One of the world’s top breast cancer doctors failed to disclose millions of dollars in payments from drug and health care companies in recent years, omitting his financial ties from dozens of research articles in prestigious publications like The New England Journal of Medicine and the Lancet.

The researcher, Dr. José Baselga, a towering figure in the cancer world, is the chief medical officer at Memorial Sloan Kettering Cancer Center in New York. He has held board memberships or advisory roles with Roche and Bristol-Myers Squibb, among other corporations; has had a stake in start-ups testing cancer therapies; and played a key role in the development of breakthrough drugs that have revolutionized treatments for breast cancer.

Read More